Dividend Investing Ideas Center
Have you ever wished for the safety of bonds, but the return potential...
Before the opening bell on Tuesday morning, Johnson & Johnson (JNJ ) reported its fourth quarter results, posting lower sales and higher earnings compared to last year’s Q4 results.
JNJ chairman and CEO Alex Gorsky had the following comments: “2014 was a strong year for Johnson & Johnson, as we delivered solid financial results while continuing to make investments to accelerate growth for the long term. We have built significant momentum in our Pharmaceutical business, are realizing the benefits of innovation, scale and breadth in our Medical Devices business and are continuing our market leadership with iconic brands in our Consumer business. I am proud of our exceptional Johnson & Johnson colleagues who make our success possible with their commitment to advancing health and well-being for patients and consumers around the world.”
Johnson & Johnson will pay its next quarterly dividend of 70 cents on March 10. The stock goes ex-dividend on February 20.
JNJ stock was down 94 cents, or 0.9%, in pre-market trading.